# US 2020/0402668 A1 · Method and kit for diagnosing non celiac gluten sensitivity

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0402668 A1
- Document ID: US20200402668A1
- Status: Published application
- Kind: A1
- Application number: 16/770,408
- Filed: 2018-12-03
- Published: 2020-12-24
- Earliest claimed: 2017-12-06
- Assignees: ALMA MATER STUDIORUM - UNIVERSITÀ Dl BOLOGNA; Azienda Ospedaliero-Universitaria Di Bologna Policlinico S. Orsola-Malpighi
- Applicants: ALMA MATER STUDIORUM - UNIVERSITÀ Dl BOLOGNA; Azienda Ospedaliero-Universitaria Di Bologna Policlinico S. Orsola - Malpighi
- Inventors: Giovanni BARBARA; Maria Raffaella BARBARO; Vincenzo STANGHELLINI; Antonio Maria MORSELLI-LABATE; Marianna MASTROROBERTO; Umberto VOLTA; Cesare CREMON
- Web page: https://patentgrep.com/patent/US20200402668A1

## CPC

- G16H 50/30: for calculating health indices; for individual health risk assessment
- G06N 7/01: Probabilistic graphical models, e.g. probabilistic networks
- G16H 10/20: for electronic clinical trials or questionnaires
- G16H 10/40: for data related to laboratory analysis, e.g. patient specimen analysis
- G16H 10/60: for patient-specific data, e.g. for electronic patient records
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G16H 50/70: for mining of medical data, e.g. analysing previous cases of other patients
- Y02A 90/10: Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G06N: COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The present invention provides means for diagnosing non celiac gluten sensitivity.

## Claims

### Claim 1

A method for diagnosing non celiac gluten sensitivity (NCGS) in a subject, comprising the following steps:
collecting clinical data indicating a degree of the severity (GS1, GS2) for one or more symptoms (S1, S2) perceived by said subject;
collecting biological data that are indicative of the zonulin concentration (ZL) in a serum sample of the subject being analysed;
elaborating said clinical and biological data to obtain a differentiation index (SC);
comparing said differentiation index with a threshold value (BC),
the NCGS being diagnosed when said differentiation index (SC) is greater than said threshold value (BC).

### Claim 2 (depends on 1)

The method according to claim 1, wherein said one or more symptoms (S1, S2) include abdominal pain and abdominal distension.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the degree of severity (GS1, GS2) of said one or more symptoms in the range 0-4.

### Claim 4 (depends on 1)

The method according to claim 1, wherein said clinical data are acquired through a questionnaire completed by said subject.

### Claim 5 (depends on 1)

The method according to claim 1, wherein said amount of serum zonulin (LZ) is expressed as the ratio of the quantity by weight of said zonulin to the amount of total protein expressed in the serum of said subject.

### Claim 6 (depends on 1)

The method according to claim 1, wherein said processing comprises a weighted sum of said clinical and biological data

### Claim 7 (depends on 6)

The method according to claim 6, wherein said weighing sum is effected with a formula of the kind:
SC=C1*(LZ)+C2*(4−GS1)+C3*GS2
wherein:
SC represents the differentiation index;
LZ represents the amount of serum zonulin;
GS1 and GS2 represent the degree of severity of the symptoms considered; and
C1, C2, C3 are weight coefficients.

### Claim 8 (depends on 7)

The method according to claim 7, wherein said weight coefficients (C1, C2, C3) are determined by means of a logistic regression analysis carried out on a reference population.

### Claim 9 (depends on 7)

The method according to claim 7, wherein said coefficients are determined as:
C1
0.0457-0.0937
C2
0.3400-0.9208
C3
0.3576-0.9196

### Claim 10 (depends on 9)

The method according to claim 9, wherein:
C1=0.0697±0.0240
C2=0.6304±0.2904, and
C3=0.6386±0.2810.

### Claim 11 (depends on 1)

The method according to claim 1, wherein said threshold value (BC) is determined as coinciding with the differentiation index corresponding to the maximum value of the curve of the likelihood ratio (LR) calculated for a reference population.

### Claim 12 (depends on 11)

The method of claim 11, wherein said curvature of the likelihood ratio (LR) is obtained by interpolation.

### Claim 13 (depends on 12)

The method according to claim 12, wherein said interpolation is carried out by means of a polynomial function, preferably of a third degree.

### Claim 14 (depends on 1)

The method according to claim 1, wherein said threshold value (BC) is comprised between 2.802 and 3.984.

### Claim 15 (depends on 14)

The method according to claim 14, wherein said threshold value (BC) is equal to 3.6760.

### Claim 16 (depends on 1)

The method according to claim 1, further comprising a step for calculating a probability (PNCGS) associated with the diagnosis of NCGS.

### Claim 17 (depends on 1)

The method according to claim 1, wherein said probability (PNCGS) associated with the diagnosis of NCGS is determined according to the formula:
PNCGS=1/(1+e−(SC−2.6208)*2.8724)
wherein 2.8724 represents an approximate value of a constant.

### Claim 18 (depends on 1)

A computer program comprising a code for implementing, when running on a computer, a method according to claim 1.

### Claim 19

A diagnostic kit for the diagnosis of non celiac gluten sensitivity (NCGS) in a subject, comprising:
a questionnaire for the acquisition of clinical data indicating a degree of the severity (GS1, GS2) for one or more symptoms (S1, S2) perceived by a subject; reagents for dosing the amount of serum zonulin (ZL) expressed in a serum sample of said subject.

### Claim 20 (depends on 19)

A kit according to claim 19, further comprising a computer program for implementing, when running on a computer, a method for diagnosing NCGS in a subject, comprising the following steps:
collecting clinical data indicating a degree of the severity (GS1, GS2) for one or more symptoms (S1, S2) perceived by said subject;
collecting biological data that are indicative of the zonulin concentration (ZL) in a serum sample of the subject being analysed;
elaborating said clinical and biological data to obtain a differentiation index (SC);
comparing said differentiation index with a threshold value (BC), the NCGS being diagnosed when said differentiation index (SC) is greater than said threshold value (BC).
